Inclusion Criteria:~* Dementia status of mild to moderate~* CT or MRI scan within 18 months prior to screening
compatible with a diagnosis of probable Alzheimer's disease~* Score on the Wechsler Memory Scale - Logical
Memory II recall below a pre-determined cut-off, adjusted for education level~* Confirmed apolipoprotein E
genotype prior to randomization~* Prior and current use of medication that corresponds with protocol
requirements~* Stable medical condition, with the exception of dementia, for at least 3 consecutive months
prior to screening~* No active suicidal thoughts within 6 months of screening, no active history of suicide
attempt in the previous 2 years, no more than 1 lifetime suicide attempt, no serious suicidal risk~* Able to
comply with protocol testing and procedures for the duration of the study~* Has a permanent caregiver
(caregiver is not expected to change during the course of the study) who is willing to attend all visits,
oversee the participant's compliance with protocol procedures and study medication administration, and report
on the participant's status~* Resides in the community (includes assisted living facilities, but excludes
long-term care nursing facilities)~* Both participant and caregiver have the ability to read and write in
English or Spanish and have hearing, vision and physical abilities adequate to perform the assessments
(corrective aids allowed)~* Participant and caregiver have provided full written informed consent prior to the
performance of any protocol-specified procedure. If participant is unable to provide informed consent due to
cognitive status, provision of informed consent by cognitively intact legally acceptable representative (where
this is in accordance with local laws, regulations and ethics committee policy)~* Participant is able to ingest
oral medication~
